Summary

Drugs of Abuse Testing Market – Scope of Report
TMR’s report on the global drugs of abuse testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drugs of abuse testing market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drugs of abuse testing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the drugs of abuse testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drugs of abuse testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drugs of abuse testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drugs of abuse testing market.

The report delves into the competitive landscape of the global drugs of abuse testing market. Key players operating in the global drugs of abuse testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drugs of abuse testing market profiled in this report.

Key Questions Answered in Global drugs of abuse testing Market Report
• What is the sales/revenue generated by drugs of abuse testing across all regions during the forecast period?
• What are the opportunities in the global drugs of abuse testing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Drugs of Abuse Testing Market – Research Objectives and Research Approach
The comprehensive report on the global drugs of abuse testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drugs of abuse testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drugs of abuse testing market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drugs of Abuse Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drugs of Abuse Testing Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Analyzers
6.3.1.1. Immunoassays Analyzers
6.3.1.2. Chromatographic Devices
6.3.1.3. Breath Analyzers
6.3.2. Rapid Testing Devices
6.3.2.1. Urine Testing Devices
6.3.2.2. Oral Fluid Testing Devices
6.3.3. Consumables
6.3.3.1. Fluid Collection Devices
6.3.3.2. Others
6.4. Market Attractiveness, by Product Type
7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Sample Type, 2017-2031
7.3.1. Saliva
7.3.2. Breath
7.3.3. Urine
7.3.4. Blood
7.3.5. Hair & Sweat
7.4. Market Attractiveness, by Sample Type
8. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Testing Type, 2017-2031
8.3.1. Pain Management Testing
8.3.2. Criminal Justice Testing
8.3.3. Workplace Screening
8.4. Market Attractiveness, by Testing Type
9. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Diagnostics Laboratories
9.3.3. On-the-spot Testing
9.3.4. Forensic Laboratories
9.4. Market Attractiveness, by End-user
10. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Drugs of Abuse Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Analyzers
11.2.1.1. Immunoassays Analyzers
11.2.1.2. Chromatographic Devices
11.2.1.3. Breath Analyzers
11.2.2. Rapid Testing Devices
11.2.2.1. Urine Testing Devices
11.2.2.2. Oral Fluid Testing Devices
11.2.3. Consumables
11.2.3.1. Fluid Collection Devices
11.2.3.2. Others
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Sample Type, 2017-2031
11.4.1. Saliva
11.4.2. Breath
11.4.3. Urine
11.4.4. Blood
11.4.5. Hair & Sweat
11.5. Market Attractiveness, by Sample Type
11.6. Market Value Forecast, by Testing Type, 2017-2031
11.6.1. Pain Management Testing
11.6.2. Criminal Justice Testing
11.6.3. Workplace Screening
11.7. Market Attractiveness, by Testing Type
11.8. Market Value Forecast, by End-user, 2017-2031
11.8.1. Hospitals
11.8.2. Diagnostics Laboratories
11.8.3. On-the-spot Testing
11.8.4. Forensic Laboratories
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Sample Type
11.11.3. By Testing Type
11.11.4. By End-user
11.11.5. By Country
12. Europe Drugs of Abuse Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Analyzers
12.2.1.1. Immunoassays Analyzers
12.2.1.2. Chromatographic Devices
12.2.1.3. Breath Analyzers
12.2.2. Rapid Testing Devices
12.2.2.1. Urine Testing Devices
12.2.2.2. Oral Fluid Testing Devices
12.2.3. Consumables
12.2.3.1. Fluid Collection Devices
12.2.3.2. Others
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Sample Type, 2017-2031
12.4.1. Saliva
12.4.2. Breath
12.4.3. Urine
12.4.4. Blood
12.4.5. Hair & Sweat
12.5. Market Attractiveness, by Sample Type
12.6. Market Value Forecast, by Testing Type, 2017-2031
12.6.1. Pain Management Testing
12.6.2. Criminal Justice Testing
12.6.3. Workplace Screening
12.7. Market Attractiveness, by Testing Type
12.8. Market Value Forecast, by End-user, 2017-2031
12.8.1. Hospitals
12.8.2. Diagnostics Laboratories
12.8.3. On-the-spot Testing
12.8.4. Forensic Laboratories
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Sample Type
12.11.3. By Testing Type
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Analyzers
13.2.1.1. Immunoassays Analyzers
13.2.1.2. Chromatographic Devices
13.2.1.3. Breath Analyzers
13.2.2. Rapid Testing Devices
13.2.2.1. Urine Testing Devices
13.2.2.2. Oral Fluid Testing Devices
13.2.3. Consumables
13.2.3.1. Fluid Collection Devices
13.2.3.2. Others
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Sample Type, 2017-2031
13.4.1. Saliva
13.4.2. Breath
13.4.3. Urine
13.4.4. Blood
13.4.5. Hair & Sweat
13.5. Market Attractiveness, by Sample Type
13.6. Market Value Forecast, by Testing Type, 2017-2031
13.6.1. Pain Management Testing
13.6.2. Criminal Justice Testing
13.6.3. Workplace Screening
13.7. Market Attractiveness, by Testing Type
13.8. Market Value Forecast, by End-user, 2017-2031
13.8.1. Hospitals
13.8.2. Diagnostics Laboratories
13.8.3. On-the-spot Testing
13.8.4. Forensic Laboratories
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Sample Type
13.11.3. By Testing Type
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Drugs of Abuse Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Analyzers
14.2.1.1. Immunoassays Analyzers
14.2.1.2. Chromatographic Devices
14.2.1.3. Breath Analyzers
14.2.2. Rapid Testing Devices
14.2.2.1. Urine Testing Devices
14.2.2.2. Oral Fluid Testing Devices
14.2.3. Consumables
14.2.3.1. Fluid Collection Devices
14.2.3.2. Others
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Sample Type, 2017-2031
14.4.1. Saliva
14.4.2. Breath
14.4.3. Urine
14.4.4. Blood
14.4.5. Hair & Sweat
14.5. Market Attractiveness, by Sample Type
14.6. Market Value Forecast, by Testing Type, 2017-2031
14.6.1. Pain Management Testing
14.6.2. Criminal Justice Testing
14.6.3. Workplace Screening
14.7. Market Attractiveness, by Testing Type
14.8. Market Value Forecast, by End-user, 2017-2031
14.8.1. Hospitals
14.8.2. Diagnostics Laboratories
14.8.3. On-the-spot Testing
14.8.4. Forensic Laboratories
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Sample Type
14.11.3. By Testing Type
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017-2031
15.2.1. Analyzers
15.2.1.1. Immunoassays Analyzers
15.2.1.2. Chromatographic Devices
15.2.1.3. Breath Analyzers
15.2.2. Rapid Testing Devices
15.2.2.1. Urine Testing Devices
15.2.2.2. Oral Fluid Testing Devices
15.2.3. Consumables
15.2.3.1. Fluid Collection Devices
15.2.3.2. Others
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Sample Type, 2017-2031
15.4.1. Saliva
15.4.2. Breath
15.4.3. Urine
15.4.4. Blood
15.4.5. Hair & Sweat
15.5. Market Attractiveness, by Sample Type
15.6. Market Value Forecast, by Testing Type, 2017-2031
15.6.1. Pain Management Testing
15.6.2. Criminal Justice Testing
15.6.3. Workplace Screening
15.7. Market Attractiveness, by Testing Type
15.8. Market Value Forecast, by End-user, 2017-2031
15.8.1. Hospitals
15.8.2. Diagnostics Laboratories
15.8.3. On-the-spot Testing
15.8.4. Forensic Laboratories
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Sample Type
15.11.3. By Testing Type
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Danaher Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Abbott
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Laboratory Corporation of America Holdings
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Drägerwerk AG & Co. KGaA
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Shimadzu Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. CareHealth America Corp.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview